FILTER

FILTERED INTERVIEW RESULTS

Robert Bloder

CHIEF BUSINESS OFFICER, ASCENDIA PHARMACEUTICALS
Ascendia Pharmaceuticals recounts the requirements to succeed in the CDMO space.

Jigar Raythatha

PRESIDENT & CEO, CONSTELLATION PHARMACEUTICALS
Constellation Pharmaceuticals explains its therapy for myelofibrosis and introduces its discovery engine.

Brad Payne & Chris Blanton & Morgan Brandt

COO & VP AND GENERAL MANAGER & GLOBAL DIRECTOR, DIGITAL PRODUCTS, PCI PHARMA SERVICES
PCI Pharma Services relates its rapid expansion in both services and geography.

Michael Quirmbach

CEO & PRESIDENT, CORDENPHARMA
CordenPharma is enjoying great demand for its increasing array of services.

Alan Petro

CEO, NEW VISION PHARMACEUTICALS
New Vision Pharmaceuticals explains how it is developing Blow-Fill-Seal technology and other services.

Thomas E. Bowens

FOUNDER AND PRESIDENT, IG GLOBAL GROUP & PRESIDENT AND CEO, TINTIC CONSOLIDATED METALS
Tintic Consolidated Metals explains to GBR how it is exploring the its’ vast gold/copper project in the Tintic district in Utah.

Manni Kantipudi & Ramesh Subramanian

CEO & CCO, ARAGEN LIFE SCIENCES
Aragen Life Sciences continues its rapid expansion and celebrates its best year ever.

Dr. Siva Samy

CEO & CHIEF PRODUCT STRATEGIST, VALGENESIS
ValGenesis explains how it streamlines the validation process to allow real-time access to validation documents and data enabling various stakeholders to achieve compliance efficiently.

Michael Kauffman

CEO, KARYOPHARM THERAPEUTICS
GBR speaks to Karyopharm Therapeutics about the commercialization of XPOVIO.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Africa Energy 2025 - Pre-release

This pre-release, containing insights from executives across leading African upstream, downstream, financing, and service providers, spotlights developments in local capabilities, infrastructure, and new projects that are driving change in some of Africa's most interesting oil and gas producing countries. 

PARTNER EVENTS